UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ------------------------------------------------- ----------------------------- Date of Report (Date of earliest event reported) March 2, 2005 ------------------------------------------------- ----------------------------- NUTRACEA -------------------------------------------------------------------------------- Exact name of registrant as specified in its charter) California 0-32565 87-0673375 -------------------------------------------------------------------------------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1261 Hawks' Flight Court, El Dorado Hills, CA 95762 -------------------------------------------------------------------------------- (Address of principal executive office Registration's telephone number, including area code: (916) 933-7000 --------------------------- -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). SECTION 5 - CORPORATE GOVERANCE AND MANAGEMENT ITEM 5.02 APPOINTMENT OF DIRECTOR. On March 2, 2005, NutraCea announced the appointment of David S. Bensol, R.Ph. to the Board of Directors. Mr. Bensol has over 30 years of experience in the medical services and pharmaceutical industries and is a licensed pharmacist. Mr. Bensol's most recent position was as CEO of Critical Homecare, Inc., a company which he founded in 2002, which provides home medical supplies and healthcare services. SECTION 9 - FINANCIAL STATEMENT AND EXHIBITS ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits -------- 99.1 Press Release dated Mach 2, 2005 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 7, 2005 NUTRACEA ----------------------------- (Registrant) /s/ Bradley D. Edson ------------------------------------ Bradley D. Edson, President